Ovarian cancer begins in the ovaries but typically goes undetected until it is found in the pelvis and abdomen, making it difficult to treat and commonly fatal. There are three types of ovarian cancer that differentiate depending on location of where it began: cancer than begins in the cells on the outside of the ovaries, cancer that begins in the egg-producing cells, and cancer that begins in the hormone-producing cells. Risk factors for ovarian cancer include inherited gene mutations, a family history of ovarian cancer, increasing age, and never being pregnant. Treatments for ovarian cancer most frequently include surgery and chemotherapy. In stage 1 of ovarian cancer, the cancer is contained in the ovaries and has not extended beyond the ovaries. Stage 1 can be divided into three subgroups. Stage IA is present when the cancer is only in one ovary and the tumor is found inside of the ovary. No cancer exists outside of the ovary. Stage IB is when cancer is present in both ovaries but not on their outer surfaces. Stage IC occurs when cancer is located in both ovaries and at least one of the following: 1) cancer is on the outside of at least one of the ovaries, 2) the capsule of the cystic tumors has burst, or 3) lab exams found cancer cells in fluid or washings from the abdomen.
Stage I Ovarian Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage I Ovarian Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 1187 products for the study of Stage I Ovarian Cancer that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Chromatin Immunoprecipitation (ChIP), Immunohistochemistry from our catalog of antibodies and ELISA kits.